Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
<h4>Background</h4>Lipoarabinomannan (LAM) is a major antigen of Mycobacterium tuberculosis (MTB). In this report, we evaluated the ability of a novel immunoassay to measure concentrations of LAM in sputum as a biomarker of bacterial load prior to and during treatment in pulmonary tuberc...
Main Authors: | Masanori Kawasaki, Carmenchu Echiverri, Lawrence Raymond, Elizabeth Cadena, Evelyn Reside, Maria Tarcela Gler, Tetsuya Oda, Ryuta Ito, Ryo Higashiyama, Kiyonori Katsuragi, Yongge Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-04-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1002780 |
Similar Items
-
Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
by: Tobias Broger, et al.
Published: (2019-01-01) -
Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
by: Natasha F. Sabur, et al.
Published: (2017-12-01) -
Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals
by: Lior Chernick, et al.
Published: (2021-07-01) -
Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
by: Hiba Younis, et al.
Published: (2019-01-01) -
Evaluation of lipoarabinomannan in the diagnosis of tuberculosis
by: Ayman A. Youssef, et al.
Published: (2016-11-01)